Insulin therapy and self-monitoring of blood glucose: Therapeutic management and recommendations;Insulinothérapie et autosurveillance glycémique: Schéma thérapeutique et recommandations

Diabetes and Metabolism

Volumn 29, Issue 2 II, 2003, Pages

  Hanaire Broutin, H ^a  

^a CHU RANGUEIL   (France)

Author keywords

Insulin therapy; Self monitoring blood glucose; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; ISOPHANE INSULIN; INSULIN;

BLOOD GLUCOSE MONITORING; CAPILLARY BLOOD; CONTINUING EDUCATION; DIABETES CONTROL; DOSE RESPONSE; DRUG FORMULATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; SELF MONITORING; BLOOD; CAPILLARY; METABOLISM; METHODOLOGY; STANDARD;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CAPILLARIES; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; PRACTICE GUIDELINES;

EID: 0037831288     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-86.
2. Charbonnel B, Boivineau C, Chopinet P, et al. Autosurveillance glycémique chez le diabétique. Recommandations de l'ALFEDIAM. Diabetes Metab, 1995, 21, 285-9.
3. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care, 1999, 22 (suppl 1), S32-S41.
4. Bolli G. How to ameliorate the problem of hypoglycemia in intensive as well as non intensive treatment of type I diabetes. Diabetes Care, 1999, 22, B43-B52.
5. Guerci B, Jeandidier N, Lassmann-Vague V, Renard E, Hanaire-Broutin H. Comment utiliser l'insuline Lispro en perfusion souscutanée continue par pompe portable ? Diabetes Metab, 2000, 26, 513-9.
6. Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypoglycemia normalize the glycemic threshold and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensive treated patients with short term IDDM. Diabetes, 1993,42, 1683-9.
7. Bott S, Bott U, Berger M, Mülhauser I. Intensified insulin therapy and the risk of severe hypoglycemia. Diabetologia, 1997, 40, 926-32.
8. Selam JL. Réévaluation du risque hypoglycémique au cours de l'insulinothérapie intensive. In Journées annuelles de Diabétologie de l'Hôtel-Dieu, París, Flammarion Médecine et Sciences, 1998, 257-80.
9. DCCT-EDIC Research Group. Retinopathy and nephropathy in patients with type I diabetes four years after a trial of intensive therapy. N Engl J Med, 2000, 342, 381-9.
10. Kraegen EW, Chisholm DI. Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy. Clin Pharmacokinet, 1985, 10,303-14.
11. Heise T, Heinemann L. Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment. Current Pharmaceutical Design, 2001, 7, 1303-25.
12. Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP, the GEDEC Study Group. Comparison of CSII and MDI regimen using insulin Lispro in type 1 diabetic patients on intensified treatment: a randomized study. Diabetes Care, 2000, 23: 1232-5.
13. Charbonnel B, Balarac N, Cazeneuve B, Augendre-Ferrante B, Le Thai F, Drouin P. Which are the insulin treatment regimens used in France. The "Schema survey". Diabetes Metab, 2001, 27, 591-7.
14. Halimi S. Apports de l'autosurveillance glycémique dans la prise en charge des diabétiques insulino (DID) et non insulinodépendants (DNID). Analyse de la littérature: des résulrats nuancés. Diabetes Metab, 1998, 24 (suppl 3), 35-41.
15. Schiffrin A, Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care, 1982, 5, 479-84.
16. Ziegler O, Kolopp M, Got I, Genron P, Debry G, Drouin P. Reliability of self-monitoring of blood glucose by CSII-treated patients with type 1 diabetes. Diabetes Care, 1989, 12, 184-8.
17. Lemozy-Cadroy S, Crognier S, Gourdy P, et al. Intensified treatment of type I diabetes: prospective evaluation at one year of a therapeutic patient education programme. Diabetes Metab, 2002, 28, 287-94.
18. Anderson B, Ho J, BrackeEt J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: relationship to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependenl diabetes mellitus. J Pediatr, 1997, 130, 257-65.
19. Lombrail P, Obadia G, Thibult N, Eschwege E, Passa P. Absence de bénéfice de l'autosurveillance glycémique chez des diabétiques insulinotraités suivis en routine dans un service spécialisé en diabétologie. Presse Med, 1986, 15, 1909-12.
20. Leese GP, Jung RT, Newton RW. Home blood glucose monitoring in patients aged over 40 years with diabetes mellitus. Practical Diabetes, 1994, 11,32-4.
21. Bott U, Jörgens V, Grüsse M, Bender R, Mühlhauser I, Berger M. Predictors of glycemic control in type I diabetic patients after participation in an intensified treatment and teaching program. Diabet Med, 1994, 11, 362-71.
22. Sachon C, Heurtier A, Grimaldi A. L'insulinothérapie dite "fonctionnelle". Diabetes Metab, 1998, 23, 556-9.